151. A novel small molecule target in human airway smooth muscle for potential treatment of obstructive lung diseases: a staged high-throughput biophysical screening
- Author
-
Steven S. An, Sudhir Sahasrabudhe, John M. Peltier, Moritz von Rechenberg, Jeffrey J. Fredberg, Thomas Zarembinski, Kwangmi Ahn, and Peter S Askovich
- Subjects
Male ,Pathology ,Time Factors ,Muscle Relaxation ,Cell ,0302 clinical medicine ,Drug Discovery ,Phosphorylation ,Lung ,0303 health sciences ,Fourier Analysis ,Molecular Structure ,Drug discovery ,Small molecule ,Bronchodilator Agents ,3. Good health ,Cell biology ,Muscle relaxation ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Signal transduction ,Signal Transduction ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Fluorescence Polarization ,In Vitro Techniques ,Biology ,Small Molecule Libraries ,Magnetics ,Structure-Activity Relationship ,03 medical and health sciences ,Heat shock protein ,medicine ,Animals ,Humans ,HSP20 Heat-Shock Proteins ,Lung Diseases, Obstructive ,030304 developmental biology ,lcsh:RC705-779 ,Dose-Response Relationship, Drug ,Research ,Reproducibility of Results ,Muscle, Smooth ,lcsh:Diseases of the respiratory system ,Surface Plasmon Resonance ,Rats, Inbred F344 ,High-Throughput Screening Assays ,Rats ,14-3-3 Proteins ,Cattle ,Ex vivo - Abstract
Background A newly identified mechanism of smooth muscle relaxation is the interaction between the small heat shock protein 20 (HSP20) and 14-3-3 proteins. Focusing upon this class of interactions, we describe here a novel drug target screening approach for treating airflow obstruction in asthma. Methods Using a high-throughput fluorescence polarization (FP) assay, we screened a library of compounds that could act as small molecule modulators of HSP20 signals. We then applied two quantitative, cell-based biophysical methods to assess the functional efficacy of these molecules and rank-ordered their abilities to relax isolated human airway smooth muscle (ASM). Scaling up to the level of an intact tissue, we confirmed in a concentration-responsive manner the potency of the cell-based hit compounds. Results Among 58,019 compound tested, 268 compounds caused 20% or more reduction of the polarized emission in the FP assay. A small subset of these primary screen hits, belonging to two scaffolds, caused relaxation of isolated ASM cell in vitro and attenuated active force development of intact tissue ex vivo. Conclusions This staged biophysical screening paradigm provides proof-of-principle for high-throughput and cost-effective discovery of new small molecule therapeutic agents for obstructive lung diseases.
- Published
- 2011
- Full Text
- View/download PDF